Jane Street’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $335K | Sell |
3,061
-808,238
| -100% | -$83.7M | ﹤0.01% | 8982 |
|
|
2026
Q1 | $84.3M | Buy |
+811,299
| New | +$86.4M | 0.01% | 732 |
|
|
2025
Q3 | – | Sell |
-299,380
| Closed | -$26.2M | – | 11542 |
|
|
2025
Q2 | $26.3M | Buy |
299,380
+270,253
| +928% | +$23.4M | 0.01% | 1198 |
|
|
2025
Q1 | $2.65M | Buy |
29,127
+9,975
| +52% | +$898K | ﹤0.01% | 3907 |
|
|
2024
Q4 | $1.65M | Sell |
19,152
-284
| -1% | -$25.7K | ﹤0.01% | 4459 |
|
|
2024
Q3 | $1.85M | Buy |
19,436
+10,759
| +124% | +$1.02M | ﹤0.01% | 4642 |
|
|
2024
Q2 | $794K | Sell |
8,677
-26,210
| -75% | -$2.34M | ﹤0.01% | 6216 |
|
|
2024
Q1 | $3.16M | Buy |
+34,887
| New | +$3.05M | ﹤0.01% | 3317 |
|
|
2023
Q4 | – | Sell |
-9,255
| Closed | -$739K | – | 9672 |
|
|
2023
Q3 | $739K | Buy |
9,255
+6,374
| +221% | +$514K | ﹤0.01% | 5625 |
|
|
2023
Q2 | $227K | Buy |
+2,881
| New | +$226K | ﹤0.01% | 7523 |
|
|
2022
Q4 | – | Sell |
-21,530
| Closed | -$1.45M | – | 9902 |
|
|
2022
Q3 | $1.45M | Sell |
21,530
-36,568
| -63% | -$2.69M | ﹤0.01% | 4742 |
|
|
2022
Q2 | $4.46M | Buy |
+58,098
| New | +$4.54M | ﹤0.01% | 2843 |
|
|
2019
Q3 | – | Sell |
-6,042
| Closed | -$354K | – | 5593 |
|
|
2019
Q2 | $354K | Buy |
+6,042
| New | +$350K | ﹤0.01% | 4007 |
|
|
2018
Q4 | – | Sell |
-5,334
| Closed | -$343K | – | 5526 |
|
|
2018
Q3 | $343K | Sell |
5,334
-20,405
| -79% | -$1.27M | ﹤0.01% | 4045 |
|
|
2018
Q2 | $1.52M | Buy |
25,739
+2,504
| +11% | +$145K | ﹤0.01% | 2249 |
|
|
2018
Q1 | $1.32M | Sell |
23,235
-4,521
| -16% | -$270K | ﹤0.01% | 2324 |
|
|
2017
Q4 | $1.65M | Buy |
27,756
+21,906
| +374% | +$1.26M | ﹤0.01% | 1771 |
|
|
2017
Q3 | $338K | Buy |
+5,850
| New | +$332K | ﹤0.01% | 3546 |
|
|
2017
Q2 | – | Sell |
-4,362
| Closed | -$241K | – | 4747 |
|
|
2017
Q1 | $241K | Buy |
+4,362
| New | +$237K | ﹤0.01% | 3672 |
|
|
2016
Q4 | – | Sell |
-8,845
| Closed | -$508K | – | 4485 |
|
|
2016
Q3 | $508K | Sell |
8,845
-8,298
| -48% | -$498K | ﹤0.01% | 2760 |
|
|
2016
Q2 | $1M | Buy |
17,143
+9,050
| +112% | +$527K | 0.01% | 1958 |
|
|
2016
Q1 | $465K | Sell |
8,093
-1,672
| -17% | -$98.9K | ﹤0.01% | 2689 |
|
|
2015
Q4 | $638K | Sell |
9,765
-37,916
| -80% | -$2.45M | ﹤0.01% | 2207 |
|
|
2015
Q3 | $3M | Sell |
47,681
-29,241
| -38% | -$2.06M | 0.02% | 702 |
|
|
2015
Q2 | $5.44M | Buy |
+76,922
| New | +$5.54M | 0.04% | 432 |
|
Other funds holding PPH
JSAM
AT
AWC
Jane Street's PPH Position: Q2 2026 in Review
Jane Street reduced its VanEck Pharmaceutical ETF (PPH) stake by 100% in Q2 2026, selling an estimated $83.7M and leaving 3,061 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #8982.
Jane Street first reported a position in PPH in Q2 2015 and has held it in 25 quarters since. The position peaked at $84.3M in Q1 2026. 139 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- Jane Street held 3,061 shares of VanEck Pharmaceutical ETF worth $335K as of Q2 2026.
- Jane Street sold 808,238 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $83.7M.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8982 holding.
- Jane Street first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and has held it in 25 quarters since.
- Jane Street's VanEck Pharmaceutical ETF position peaked at $84.3M in Q1 2026.
- 139 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.